These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9037848)
1. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension. Huang JL; Cheng FC; Chen YT; Ting CT Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848 [TBL] [Abstract][Full Text] [Related]
2. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension. Ding YA; Chang SM; Chou TC J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379 [TBL] [Abstract][Full Text] [Related]
3. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension. Sánchez S; Luna A; Orozco R; Velasco G Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922 [TBL] [Abstract][Full Text] [Related]
4. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents. Canter DA; Texter MJ; McLain RW J Hypertens Suppl; 1994; 12(7):S33-8. PubMed ID: 7769502 [TBL] [Abstract][Full Text] [Related]
5. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM]. Motero Carrasco J Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944 [TBL] [Abstract][Full Text] [Related]
6. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397 [TBL] [Abstract][Full Text] [Related]
7. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording. MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377 [TBL] [Abstract][Full Text] [Related]
8. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching. Larochelle P; Haynes B; Maron N; Dugas S Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244 [TBL] [Abstract][Full Text] [Related]
9. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients? Ruzicka M; Coletta E; Leenen FH Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension. Radevski IV; Valtchanova ZP; Candy GP; Hlatswayo MN; Sareli P J Clin Pharmacol; 2000 Jul; 40(7):713-21. PubMed ID: 10883412 [TBL] [Abstract][Full Text] [Related]
11. The pharmacodynamic responses of hypertensive patients to quinapril therapy. Fernandez PG; Snedden W Can J Cardiol; 1992 Mar; 8(2):189-94. PubMed ID: 1559192 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure. Sedman AJ; Posvar E Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762 [TBL] [Abstract][Full Text] [Related]
13. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function. Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710 [TBL] [Abstract][Full Text] [Related]
14. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension. Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540 [TBL] [Abstract][Full Text] [Related]
15. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension. Weir MR J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504 [TBL] [Abstract][Full Text] [Related]
16. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group. Larochelle P Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779 [TBL] [Abstract][Full Text] [Related]
17. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study. Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140 [TBL] [Abstract][Full Text] [Related]
18. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046 [TBL] [Abstract][Full Text] [Related]
19. Effect of losartan on nocturnal blood pressure in patients with stroke: comparison with angiotensin converting enzyme inhibitor. Okuguchi T; Osanai T; Fujiwara N; Kato T; Metoki N; Konta Y; Okumura K Am J Hypertens; 2002 Nov; 15(11):998-1002. PubMed ID: 12441222 [TBL] [Abstract][Full Text] [Related]
20. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours? Palatini P Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]